title: Everolimus in HR-positive advanced breast cancer.
authors.forename: Suleiman
authors.initials: S
authors.lastname: Massarweh
authors.forename: Jessica
authors.initials: J
authors.lastname: Croley
authors.forename: Heidi
authors.initials: H
authors.lastname: Weiss
mesh_terms: D000730:Androstadienes / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D020123:Sirolimus / Q000031:analogs & derivatives*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D000730:Androstadienes; D047072:Aromatase Inhibitors; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus